A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Clinical trial NCT04931147 · COMPLETED

Trial details

NCT number: NCT04931147
Sponsor: Redx Pharma Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Fibrosis Inflammation Idiopathic Pulmonary Fibrosis Non-alcoholic Steatohepatitis Liver Diseases Kidney Diseases

Start date: 2021-05-13
Primary completion: 2023-03-08
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.